SSB 5240
| Momentum Bucket | Strong Momentum |
| Legal Title | AN ACT Relating to anaphylaxis medications in schools; |
| Bill Description | Concerning anaphylaxis medications in schools. |
|
What this bill does
Powered by Legitron |
Not available yet. |
|
Why it matters
Powered by Legitron |
Not available yet. |
| Official Documents | View Full Bill Text |
SSB 5240 Position - A premium account is required to save position information.
SSB 5240 Details and Bill Topics
SSB 5240 Sponsors and Committee Hearings
Sponsors
| Senator Wellman (Primary) |
| Senator Slatter |
| Senator Boehnke |
| Senator Hasegawa |
| Senator Nobles |
| Senator Stanford |
| Senator Trudeau |
| Senator C. Wilson |
Committee Hearings
| Hearing | Senate Early Learning & K-12 Education (Public) |
| Hearing | Senate Early Learning & K-12 Education (Executive) |
| Hearing | House Education (Public) |
| Hearing | House Education (Public) |
| Hearing | House Education (Executive) |
SSB 5240 Bill Timeline
Strong Momentum
3/3/2026
SRules 3
Rules Committee relieved of further consideration. Placed on second reading.
2/24/2026
SRules 3
Referred to Rules 2 Review.
2/22/2026
SRules 3
ED - Majority; do pass with amendment(s).
2/22/2026
SRules 3
ED - Executive action taken by committee.
1/12/2026
SRules 3
Placed on third reading by Rules Committee.
1/11/2026
SRules 3
By resolution, reintroduced and retained in present status.
4/26/2025
SRules 3
By resolution, returned to Senate Rules Committee for third reading.
3/11/2025
SRules 3
First reading, referred to Education.
3/9/2025
SRules 3
Third reading, passed; yeas, 49; nays, 0; absent, 0; excused, 0.
3/9/2025
SRules 3
Rules suspended. Placed on Third Reading.
3/9/2025
SRules 3
1st substitute bill substituted.
3/4/2025
SRules 3
Placed on second reading by Rules Committee.
2/11/2025
SRules 3
Passed to Rules Committee for second reading.
2/10/2025
SRules 3
EDU - Majority; 1st substitute bill be substituted, do pass.
1/13/2025